Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution

por Salati, Massimiliano, Baldessari, Cinzia, Cerbelli, Bruna, Botticelli, Andrea
Publicado no Transl Lung Cancer Res (2018)

CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy

por Sacchetti, Benedetto, Botticelli, Andrea, Pierelli, Luca, Nuti, Marianna, Alimandi, Maurizio
Publicado no Int J Mol Sci (2019)

Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis

por Marchetti, Paolo, Botticelli, Andrea, Ascierto, Antonio Paolo, Curigliano, Giuseppe, Giannarelli, Diana
Publicado no J Transl Med (2020)

Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors

por Vici, Patrizia, Pizzuti, Laura, Krasniqi, Eriseld, Botticelli, Andrea, Ciliberto, Gennaro, Barba, Maddalena
Publicado no Immunotherapy (2020)

Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong

por Occhipinti, Mario, Falcone, Rosa, Onesti, Concetta Elisa, Botticelli, Andrea, Mazzuca, Federica, Marchetti, Paolo, Lauro, Salvatore
Publicado no J Thorac Dis (2017)

Biliary tract cancer: current challenges and future prospects

por Ghidini, Michele, Pizzo, Claudio, Botticelli, Andrea, Hahne, Jens Claus, Passalacqua, Rodolfo, Tomasello, Gianluca, Petrelli, Fausto
Publicado no Cancer Manag Res (2018)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression

por Roberto, Michela, Falcone, Rosa, Mazzuca, Federica, Archibugi, Livia, Castaldi, Nadia, Botticelli, Andrea, Osti, Mattia Falchetto, Marchetti, Paolo
Publicado no Medicine (Baltimore) (2017)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer

por Mezi, Silvia, Botticelli, Andrea, Pomati, Giulia, Cerbelli, Bruna, Scagnoli, Simone, Amirhassankhani, Sasan, d’Amati, Giulia, Marchetti, Paolo
Publicado no Cancers (Basel) (2021)

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient

por Crimini, Edoardo, Roberto, Michela, Degli Effetti, Valter, Marchetti, Paolo, Botticelli, Andrea, Schipilliti, Francesca Matilde, Arrivi, Giulia, Mazzuca, Federica
Publicado no Case Rep Oncol Med (2019)

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

por Botticelli, Andrea, Zizzari, Ilaria, Mazzuca, Federica, Ascierto, Paolo Antonio, Putignani, Lorenza, Marchetti, Luca, Napoletano, Chiara, Nuti, Marianna, Marchetti, Paolo
Publicado no Oncotarget (2016)

Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy

por Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Aimati, Laura, Gentile, Giovanna, Capalbo, Carlo, Maddalena, Chiara, Mazzotti, Eva, Simmaco, Maurizio, Marchetti, Paolo
Publicado no World J Oncol (2015)

Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines

por Mazzuca, Federica, Onesti, Concetta Elisa, Roberto, Michela, Di Girolamo, Marco, Botticelli, Andrea, Begini, Paola, Strigari, Lidia, Marchetti, Paolo, Muscaritoli, Maurizio
Publicado no Oncotarget (2018)

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

por Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo
Publicado no J Transl Med (2018)

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options

por Grizzi, Giulia, Ghidini, Michele, Botticelli, Andrea, Tomasello, Gianluca, Ghidini, Antonio, Grossi, Francesco, Fusco, Nicola, Cabiddu, Mary, Savio, Tommaso, Petrelli, Fausto
Publicado no Cancer Manag Res (2020)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions

por Ralli, Massimo, Botticelli, Andrea, Visconti, Irene Claudia, Angeletti, Diletta, Fiore, Marco, Marchetti, Paolo, Lambiase, Alessandro, de Vincentiis, Marco, Greco, Antonio
Publicado no J Immunol Res (2020)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

por Lazzaro, Carlo, Bordonaro, Roberto, Cognetti, Francesco, Fabi, Alessandra, De Placido, Sabino, Arpino, Grazia, Marchetti, Paolo, Botticelli, Andrea, Pronzato, Paolo, Martelli, Elisa
Publicado em 2013

CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy

por Mazzuca, Federica, Botticelli, Andrea, Mazzotti, Eva, La Torre, Marco, Borro, Marina, Marchetti, Luca, Maddalena, Chiara, Gentile, Giovanna, Simmaco, Maurizio, Marchetti, Paolo
Publicado no Eurasian J Med (2016)

Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort

por Mazzuca, Federica, Borro, Marina, Botticelli, Andrea, Mazzotti, Eva, Marchetti, Luca, Gentile, Giovanna, La Torre, Marco, Lionetto, Luana, Simmaco, Maurizio, Marchetti, Paolo
Publicado no Oncotarget (2016)

How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches

por Ghidini, Michele, Petrillo, Angelica, Botticelli, Andrea, Trapani, Dario, Parisi, Alessandro, La Salvia, Anna, Sajjadi, Elham, Piciotti, Roberto, Fusco, Nicola, Khakoo, Shelize
Publicado no J Clin Med (2021)

Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study

por Mazzuca, Federica, Roberto, Michela, Arrivi, Giulia, Sarfati, Elena, Schipilliti, Francesca Matilde, Crimini, Edoardo, Botticelli, Andrea, Di Girolamo, Marco, Muscaritoli, Maurizio, Marchetti, Paolo
Publicado no Integr Cancer Ther (2019)